Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) has been given an average recommendation of “Hold” by the seven analysts that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company.
Several equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Straumann in a report on Tuesday, June 30th. Barclays reissued an “overweight” rating on shares of Straumann in a research report on Thursday, June 18th. BMO Capital Markets started coverage on shares of Straumann in a research note on Wednesday, July 8th. They set an “outperform” rating on the stock. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a report on Thursday, July 9th.
Check Out Our Latest Research Report on Straumann
Straumann Trading Down 3.3%
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Featured Stories
- Five stocks we like better than Straumann
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
